ArticleFrontiers in oncology2023

Young patients show poor efficacy for immune checkpoint inhibitor combined therapy in metastatic gastrointestinal cancers.

Yingnan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.